Element Biosciences announced a collaboration with TrendBio to support the development of their genomic technologies. TrendBio will provide Element Biosciences with access to their advanced sequencing and data analysis technologies, as well as expertise in genomics and bioinformatics.
The partnership will enable Element Biosciences to accelerate the development of their genomic platform and expand their capabilities in high-throughput sequencing, single-cell analysis, and other areas of genomics research. The collaboration will also provide TrendBio with an opportunity to collaborate with a leading genomics company and further develop their expertise in the field.
"The partnership with Element Biosciences complements our existing genomics portfolio and brings a highly innovative platform for accurate and scalable sequencing at a lower price point. The Aviti system will significantly advance DNA sequencing for a wide range of applications and TrendBio is excited to play a role in enabling this technology for our Australian and New Zealand customer base" said Trent Warburton, Director of TrendBio Pty Ltd.
The partnership will enable Element Biosciences to accelerate the development of their genomic platform and expand their capabilities in high-throughput sequencing, single-cell analysis, and other areas of genomics research. The collaboration will also provide TrendBio with an opportunity to collaborate with a leading genomics company and further develop their expertise in the field.
"The partnership with Element Biosciences complements our existing genomics portfolio and brings a highly innovative platform for accurate and scalable sequencing at a lower price point. The Aviti system will significantly advance DNA sequencing for a wide range of applications and TrendBio is excited to play a role in enabling this technology for our Australian and New Zealand customer base" said Trent Warburton, Director of TrendBio Pty Ltd.
